SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-15-000039
Filing Date
2015-08-05
Accepted
2015-08-05 17:06:29
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks201563010-q.htm 10-Q 461636
2 EXHIBIT 10.4 flks2015630ex-104.htm EX-10.4 12393
3 EXHIBIT 31.1 flks2015630ex-311.htm EX-31.1 9460
4 EXHIBIT 31.2 flks2015630ex-312.htm EX-31.2 9494
5 EXHIBIT 32.1 flks2015630ex-321.htm EX-32.1 9335
  Complete submission text file 0001615219-15-000039.txt   2459620

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flks-20150331.xml EX-101.INS 345066
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20150331.xsd EX-101.SCH 20499
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20150331_cal.xml EX-101.CAL 37517
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20150331_def.xml EX-101.DEF 96046
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20150331_lab.xml EX-101.LAB 309312
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20150331_pre.xml EX-101.PRE 180825
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 151029798
SIC: 2834 Pharmaceutical Preparations